Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
The Pro Medicus Ltd (ASX:PME) share price is in focus after the ASX healthcare share won a new contract with Novant Health.
If I had $5.000 to invest into ASX tech shares, I know which ones that I’d want to buy for my portfolio, like Redbubble Ltd (ASX:RBL).
Here are two ASX shares that certainly don’t come cheap… Pro Medicus (ASX:PME) and Objective Corporation (ASX:OCL).
The Nanosonics Ltd (ASX: NAN) share price has gone bonkers this morning, up 18% to $6.99 as the market reacts to its latest product release.
A look at Pro Medicus Ltd (ASX:PME), Redbubble Ltd (ASX:RBL), Nearmap Ltd (ASX:NEA), CSL Limited (ASX:CSL), Netwealth Ltd (ASX:NWL), AVA Risk Group Ltd (ASX:AVA) and Upstart Inc (NASDAQ:UPST).
The S&P/ASX 200 (ASX: XJO) fell another four points on Friday, capping a full week of lower closes and a loss of 2.2% for the five days.
Pro Medicus Limited (ASX: PME) is the ASX share I wish I owned. After the latest FY21 result, what’s the verdict on its shares?
Could Pro Medicus Ltd (ASX:PME) be the best ASX share after the medical imaging healthcare company released its FY21 result?
Some of the ASX shares are so good that I’d want them in my portfolio. But only if I could buy them at a good value price…
